Join Waitlist

The Illusion of Science vs. The Reality of Evidence: Why the Supplement Industry Must Evolve

September 9, 2025

Introduction – Stripping Away the Illusion

For decades, supplement companies have marketed themselves as “science-driven” and “evidence-based.” The labels sound good. The claims are compelling. But after decades of evaluating dozens of supplement brands and ingredient portfolios, including during my work in mergers and acquisitions at Sanofi, I’ve seen a sobering truth:

An estimated 70 to 80% of products and ingredients in the supplement industry would score Bronze or lower if evaluated objectively. What’s the actual number? I don’t know, but we are going to find out once NutriSelect is on the market.

And why is that hard to assess? Because the industry today operates primarily subjectively when it comes to science.

That gap between perception and reality is what I call the illusion of science vs. the reality of evidence.

It’s a hard truth our industry must face. It’s the elephant in the room no one wants to focus on. However, it’s also an opportunity for those willing to lead with genuine evidence rather than marketing spin.

 The Illusion of Science

At first glance, the illusion is convincing. Companies say their products are “clinically studied,” “science-backed,” or “proven effective.” But when you look closer, those claims often rest on shaky ground. After completing due diligence on dozens of brands, many of those multimillion dollar businesses and brands you would know, it was shocking to see the lack of scientific evidence. And what had been “rationalized” to scientifically support claims.

Here are the common hallmarks of the illusion:

  • Borrowed Science: Leaning on generic ingredient studies instead of conducting research on the actual product or ingredient being sold.
  • Cherry-Picked Data: Highlighting one favorable result while ignoring contradictory or inconclusive studies.
  • Buzzword-Driven Marketing: Using scientific language as a veneer without real substantiation.
  • Minimal Validation: Relying on small, underpowered trials that cannot withstand scrutiny.
  • Outdated Technology: Still making claims on years old technology that is no longer relevant or with expired patents.

Why does the illusion persist? Because it’s easier, faster, and cheaper. Real science requires investment, patience, and expertise. Many companies feel pressure to launch products quickly, cut corners, or simply assume “what’s in the market must be good enough” or “I’m not required to do studies” or “I need to keep up with the Joneses”. Sadly, many of the companies we performed due diligence on didn’t even have scientific people on staff. If they did, they lacked the technical expertise or they were outsourcing so called “scientific experts”.

The Myth of Cost: Why Companies Say They Can’t Afford Research

One of the most common objections I hear from supplement brands and ingredient companies is that “research is too expensive.” I heard that repeatedly when running my own CRO (Contract Research Organization) in this industry some years ago. On the surface, it sounds reasonable. Clinical studies require funding, time, and expertise. For brands focused on sales growth, trade shows, and marketing, research can feel like a luxury; something to do later, once revenue grows.

But this reasoning is fundamentally flawed. The real cost isn’t in doing research — it’s in not doing research.

Here’s why:

  • Short-Term Thinking vs. Long-Term Value
    Many brands cut corners on formulations to save money. They cheapen ingredients, lower dosages, or skip validation entirely. While this may reduce costs upfront, it results in products that underperform. Consumers don’t feel the promised benefits, and churn rates skyrocket.
  • The Churn Problem
    In the supplement space, customer retention for average products often sits in the 20–25% range. That means 3 out of 4 customers never buy again. By contrast, when I developed my own science-backed products, my customer retention consistently hit 75% or more. Why? Because the difference wasn’t marketing; it was evidence. Consumers stayed because the products delivered results.
  • Misallocation of Budget
    Most companies aren’t short on money; they’re short on priorities. Huge sums are poured into marketing campaigns designed to acquire new customers, while very little is spent on research that could keep customers. If even a fraction of that marketing spend were redirected into research, companies could reduce churn, spend less on acquisition, and increase long-term profitability.

The truth is that research isn’t a cost center — it’s a growth driver. The myth that “we can’t afford research” is really a way of saying “we don’t want to change.” And today there are several leading CROs that are changing the industry and the way we do clinical studies while bringing down costs. So, there is really no excuse anymore. Several of those CROs are NutriSelect’s partners.

The companies that pivot, invest in evidence, and prove efficacy will not only retain more customers; they will define the future of the industry.

The Reality of Evidence

True evidence looks very different. It’s built on:

  • Well-designed, peer-reviewed clinical trials conducted on the actual ingredient or product.
  • Transparent, reproducible data that stands up to independent review.
  • Claims that align with the science — matched to endpoints, dosages, and populations studied.
  • Scientific authority built through published studies, abstracts, and regulatory-appropriate positioning.

The gap between illusion and reality is vast. And the consequences are mounting:

  • Consumers are losing trust. They’re bombarded with products making bold claims, but too often left disappointed by results.
  • Regulators are tightening standards. Agencies are scrutinizing claims and requiring stronger substantiation.
  • Investors and retailers are demanding credibility. Science-backed brands command better partnerships, higher valuations, and stronger shelf space.

In other words, the illusion is cracking, and the reality is catching up fast.

Why This Matters Now

We’ve reached an inflection point in the supplement industry. For too long, marketing has outpaced science. The result is a crowded market full of products that look good on paper but lack the evidence to truly back them up.

Companies that continue down this path will find themselves exposed to regulators, to skeptical consumers, and to competitors who choose to embrace real evidence. The advances in AI technology are rapidly accelerating that landscape, as well as creating changes in many other industries. It’s here to stay.

The future belongs to those who pivot from illusion to reality. Those who are willing to ask the hard question:

When the illusion is stripped away, will our science stand up to the evidence?

How NutriSelect is Changing the Game

At NutriSelect, our mission is to transform the supplement industry from marketing-driven to science-driven. We do this through two key innovations:

  1. The Patent-Pending NScore™ Benchmark and Precision Supplement Intelligence™ Platform

A transparent, objective rating system that evaluates ingredients and products against rigorous evidence standards. Instead of relying on subjective judgment, NScore™ provides a clear, numerical score and tiered rating (Gold, Silver, Bronze or below). The platform is operating today in our Accelerator programs. And the app leveraging this platform will be in the hands of supplement consumers next year.

  1. Science Accelerator Programs
  • Ingredient Science Accelerator: A 12-month program helping ingredient companies validate science, identify research gaps, and strengthen their credibility.
  • Product Science Accelerator: A parallel program for supplement brands to audit SKUs, prioritize flagships, and design clinical strategies.

Together, these programs provide a complete ecosystem for companies ready to move beyond illusion and invest in evidence.

A Pilot Path: Seeing the Reality Firsthand

We understand that skepticism exists. Many companies believe they are advanced in their science. The truth is they are not. They don’t know what they don’t know. That’s why we created the Pilot NScore™ Demo — a low-barrier way to test one product or ingredient and see the results.

The process is simple:

  • Choose one ingredient or product from your portfolio.
  • Provide the supporting data package.
  • Receive a high-level NScore™ snapshot and gap summary.

In our experience, most of these snapshots land in the Bronze tier or below. While that may sound discouraging, it’s actually the starting point for growth. From there, companies can choose to dive deeper with a full audit or join the Accelerator to systematically improve their science and credibility. Once you acknowledge the gap there’s no going back. It’s just a mathematical reality. The data is the data.

The Path Forward

The supplement industry doesn’t need more claims. It doesn’t need more products either. It needs more evidence.

It doesn’t need more marketing spin. It needs more science-driven credibility.

At NutriSelect, we’re building the tools, benchmarks, and programs to make this possible.

But ultimately, the choice lies with each company:

Will you continue to operate under the illusion of science?

Or will you step into the reality of evidence and position your brand as a leader in the next era of supplementation?

Take the red pill.

About the Author
Dr. Bill Clark, PhD is the Founder & CEO of NutriSelect.ai, an AI-powered platform advancing evidence-based supplementation. With nearly 30 years of experience in the natural products industry, including leading science and M&A evaluation for Sanofi, he now works to transform the industry from marketing-driven to science-driven through the NScore™ rating system and NutriSelect’s Accelerator programs.